Mangoceuticals

(NASDAQ) MGRX

Current Price$0.37

Market Cap$6.12M

Since IPO (2023)-99%

5 YearN/A

1 Year-82%

1 Month+5%

Mangoceuticals Financials at a Glance

Market Cap

$6.12M

Revenue (TTM)

$414.58K

Net Income (TTM)

-$19.21M

EPS (TTM)

-$1.62

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.37

Volume

212,163.398

Open

$0.36

Price

$0.37

Volume

212,163.398

Open

$0.36

Previous Close

$0.36

Daily Range

$0.35 - $0.38

52-Week Range

$0.16 - $2.75

Estimated Earnings Date

May 19, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.37

Volume

212,163.398

Open

$0.36

Previous Close

$0.36

Daily Range

$0.35 - $0.38

52-Week Range

$0.16 - $2.75

Estimated Earnings Date

May 19, 2026

MGRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mangoceuticals

Industry

Food and Staples Retailing

Sector

Consumer Staples

Employees

CEO

Jacob D. Cohen

Website

www.mangoceuticals.com

Headquarters

Dallas, TX 75248, US

MGRX Financials

Key Financial Metrics (TTM)

Gross Margin

52%

Operating Margin

-42%

Net Income Margin

-46%

Return on Equity

-114%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

-3.06%

Stock Overview

Market Cap

$6.12M

Shares Outstanding

17.17M

Volume

212.16K

Avg. Volume

5.92M

Financials (TTM)

Gross Profit

$250.39K

Operating Income

-$19.15M

EBITDA

-$18.82M

Operating Cash Flow

-$5.85M

Capital Expenditure

-$5.00

Free Cash Flow

-$5.85M

Cash & ST Invst.

$1.49M

Total Debt

$307.82K

Mangoceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$67.86K

-37.9%

Gross Profit

$29.00K

-53.3%

Gross Margin

42.73%

N/A

Market Cap

$6.12M

N/A

Market Cap/Employee

$2.04M

N/A

Employees

N/A

Net Income

-$3.40M

+29.7%

EBITDA

-$3.13M

+29.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$174.56K

+128.2%

Total Debt

$294.02K

+516.2%

Accounts Receivable

$20.06K

N/A

Inventory

$0.00

N/A

Long Term Debt

$236.97K

N/A

Short Term Debt

$57.06K

+19.6%

Return on Assets

-1.33%

N/A

Return on Invested Capital

-1.27%

N/A

Free Cash Flow

-$1.31M

+42.4%

Operating Cash Flow

-$1.31M

+42.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HCTIHealthcare Triangle, Inc.

HCTIHealthcare Triangle, Inc.$2.23-8.23%

CASICASI Pharmaceuticals, Inc.

CASICASI Pharmaceuticals, Inc.$0.15+3.08%

VSEEVSee Health, Inc.

VSEEVSee Health, Inc.$0.14-8.97%

CLSDClearside Biomedical, Inc.

CLSDClearside Biomedical, Inc.$0.41+0.00%

ASBPAspire Biopharma Holdings, Inc.

ASBPAspire Biopharma Holdings, Inc.$4.96-17.33%

FEMYFemasys Inc.

FEMYFemasys Inc.$4.18-12.55%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About MGRX

What is the current price of Mangoceuticals?

Mangoceuticals is trading at $0.36 per share.

What is the 52-week range for Mangoceuticals?

Over the past 52 weeks, Mangoceuticals has traded between $0.16 and $2.75.

How much debt does Mangoceuticals have?

As of the most recent reporting period, Mangoceuticals reported total debt of $294.02K.

How much cash does Mangoceuticals have on hand?

Mangoceuticals reported $174.56K in cash and cash equivalents in its most recent financial results.

What is Mangoceuticals’s dividend yield?

Mangoceuticals does not currently have a dividend yield.

Mangoceuticals

Mangoceuticals Financials at a Glance

MGRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mangoceuticals

MGRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mangoceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MGRX

What is the current price of Mangoceuticals?

What is the 52-week range for Mangoceuticals?

How much debt does Mangoceuticals have?

How much cash does Mangoceuticals have on hand?

What is Mangoceuticals’s dividend yield?

Premium Investing Services